Drugmaker Lilly says Covid treatment slashed hospitalization and deaths
Sharp reductions in costs of producing cannabis, fentanyl likely to spur widespread changes in use, dependence
10 March 2021Recuperation unit decreased hospitalizations of homeless individuals with COVID-19
10 March 2021Drugmaker Lilly says Covid treatment slashed hospitalization and deaths
US drugmaker Eli Lilly’s combination of two synthetic antibodies reduced hospitalizations and deaths in high-risk patients recently diagnosed with COVID-19 by 87 percent in trials, the company said Wednesday.
